德納維製藥股票討論區

Dynavax Technologies' long-term performance remains strong despite a recent 8.6% pullback. The company's profit growth is commendable, and its 15% annual gain, though below market return, surpasses its 5-year average, suggesting a successful strategy attracting new investors.

📈 Stock #1 - SoFi 📈
Dr. Stock is bullish on SoFi, considering it a fundamental long-term play with potential growth. He's eagerly awaiting Q2 earnings to see if they stay on track to achieve profitability by Q4 2023. Dr. Stock talks about possible price drops in the short term, which could create great buying opportunities for the long term. He also discusses potential resistance levels and trade plays as the stock approaches key price points.
🚗 Stock #2 - Tes...

Welcome back to the channel! In this video, Dr. Stock, a doctor of Education, will be discussing various stocks, including some he recently mentioned in his previous videos. He provides updates on Sofi and Tesla as well. Dr. Stock focuses on stocks that are currently not hyped up, which makes their technical analysis more predictable compared to heavily hyped stocks like pure play A.I. stocks.
To analyze these stocks, Dr. Stock uses Moomoo, a platform where you can get up...

Let's start with C3.ai. Recently, we witnessed an interesting pattern where the stock showed significant movement. In a previous video, I mentioned that this stock was expected to experience a substantial move, although the direction was uncertain. This presented an opportunity for options plays like the long straddle or long strangle to take advantage of the expected volatility.
If you are unfamiliar with options, there are alternative ways to play volatility. However, it's...